Clinical effectiveness and effect on COX-2 expression of the sequential treatment of actinic keratoses (AK) with photodynamic therapy (PDT) and diclofenac 3% gel: a phase IV clinical trial

Registry ID

EUCTR2013-000110-37

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Fundacion para la investigación biomédica del hospital Ramón y Cajal de Madrid

Start date

2013-03-18

Last update

2026-08-16

Conditions

• Actinic keratosis

Summary

The aim of this study is to evaluate the effectiveness of the combination of PDT and topical 3% diclofenac gel in combination for treating AKs (using the reduction of at least 75% of the number of AKs as our primary endpoint) compared with the application of two sessions of PDT

Locations

• , , Spain

Related clinical trials

• An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod® (imiquimod 50 mg/g, Gel) compared with Aldara® (imiquimod 50 mg/g, Cream) for the treatment of actinic keratosis in adults.

View on source registry